[1]Peroutka S J. 5-Hydroxytryptamine receptors[J]. Journal of Neurochemistry, 1993, 60(2): 408-416.
[2]刘飞,贺佑丰,罗志福. 中枢神经系统5-羟色胺受体显像剂WAY类似物的研究进展[J]. 同位素,2001,14(1):41-49(in Chinese).Liu fei, He youfeng, Luo zhifu. Development progress of WAY analogues in CNS 5-hydroxytrypamine receptor imaging agents[J]. Journal of Isotopes, 2001, 14(1): 41-49(in Chinese).
[3]Shen Y, Monsma F J, Metcalf M A. Molecular cloning and expression of a 5-hydroxytrypamine7 serotonin receptor subtype[J]. Journal of Biological Chemistry, 1993, 268(24): 18200-18204.
[4]Middlemiss D N, Fozard J R. 8-hydroxy-2 (di-n-propylamino)-tetralin discriminated between subtypes of 5-HT1A recognition site[J]. European Journal of Pharmacology, 1983, 90(1): 151-153.
[5]陆春雄,吴春英,蒋泉福. 5-HT1A受体拮抗剂WAY-100635的合成[J]. 中国医药工业杂志,2005,36(7):391-392.Lu chunxiong, Wu chunying, Jiang Quanfu. Synthesis of 5-HT1A receptor antagonist WAY-100635[J]. Chinese Journal of Pharmaceuticals, 2005, 36(7): 391-392(in Chinese).
[6]Ian A C. A retrospect on the discovery of WAY-100635 and the prospect for improved 5-HT1A receptor PET radioligands[J]. Nuclear Medicine &Biology. 2000, 27: 441-447.
[7]Farde L. The advantage of using positron emission tomography in drug research[J]. Trends Neurosci. 1996, 19(6): 211-214.
[8]Glenmon R A. Central serotonin receptors as targets for drug research[J]. Journal of Medical Chemistry, 1987, 30: 1-12.
[9]Glenmon R A, Naiman N A, Pierson M E. N-(phthanlimidoalkyl) aerrvatires of serotonergic agents: a common interaction at 5-HT1A serotonin binding sites?[J]. Journal of Medical Chemistry. 1989, 32(8): 1921-1926.
[10]Victor W P, Julie A M, Suan P H. et al. Pre-clinical development of a radioligand for studies of central 5-HT1A Receptors in vivo-[11C]-WAY-100635[J]. Medicinal Chemistry Research, 1994, 5: 208-227.
[11]张锦明,田嘉禾,姚树林,等. 11C-Raclopride的快速制备及生物学评价[J]. 中华核医学杂志,2008,28(4):227-230.Zhang jinming, Tian jiahe, Yao shulin, et al. Fast synthesis of 11C-Raclopride and its initial PET study on animal model[J]. Chinese Journal of Nuclear Medicine. 2008, 28(4): 227-230(in Chinese).
[12]Gao M, Gao A, Wang M, et al. Synthesis of carbon-11-labeled aminoalkylindole derivatives as new candidates of cannabinoid receptor radioligands for PET imaging of alcohol abuse[J]. Bioorganic & Medicinal Chemistry Letters. 2014, 24(24): 5581-5586.
[13]Gao M, Wang M, Green M A, et al. Synthesis of [11C]-GSK1482160 as a new PET agent for targeting P2X7 receptror[J]. Bioorganic & Medicinal Chemistry Letters, 2015, 25(9): 1965-1970.
[14]Krasikova R, Fedorova O, Korsakov M, et al. A fast and convenient method for robtic preparation of 11C-flumazenil avoiding HPLC purification[J]. Journal of Labeled Compounds & Radiopharmaceuticals, 2000, 43: 613-621.
[15]Wang M, Gao M, Miller K D, et al. Synthesis of [11C]PBR06 and [18F]PBR06 as agents for position emission tomographic (PET) imaging of the translocator protein (TSPO)[J]. Steroids, 2011, 76(12): 1331-1340.
[16]许莉莉. 5-HT1A受体及其与抑郁症相关性的研究进展[J]. 中国医药导报,2012,9(3):16-17,20.Xu lili. Progress of correlation study between 5-HT1A receptor and depression[J]. China Medical Herald, 2012, 9(3): 16-17, 20(in Chinese). |